MedPath

Neonatal Evaluation of Norepinephrine Infusion in Spinal Anesthesia for Cesarean Section

Completed
Conditions
Caesarean Section;Stillbirth
Registration Number
NCT04245891
Lead Sponsor
Centre Hospitalier Universitaire de Nīmes
Brief Summary

This retrospective study aims to evaluate the fate of children born by cesarean section under spinal anesthesia with or without norepinephrine as vasopressor support for anesthesia. The main objective is to compare the initial Apgar score. The records of patients who received norepinephrine are compared to those without norepinephrine. To limit the biases of this type of study, the investigators will apply a propensity score that will include as a variable: age, ASA score, comorbidity, urgency. The patients analysed correspond to the period 2016-2017.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
265
Inclusion Criteria
  • age > 18
  • Spinal Anesthesia for Cesarean Section
Exclusion Criteria
  • sub epidural cesarean section
  • contraindication to spinal anesthesia (allergy, severe heart disease, coagulopathy)

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
lactate levelJust after the birth of the newborn baby

The primary endpoint is the Umbilical Cord Lactate levels

Secondary Outcome Measures
NameTimeMethod
Umbilical Cord venous PHJust after the birth

Umbilical Cord venous PH

maternal arterial tension during cesarean section0, 5,10,15, 20 25, 30,35,40 minutes after spinal anesthesia

maternal arterial tension during cesarean section

incidences of mother nausea and vomitingfrom beginning to cesarean section end

incidences of mother nausea and vomiting

use of vasopressorsfrom beginning to cesarean section end

use of vasopressors

APGAR Score1, 5 and 10 minutes after birth

APGAR Score

Umbilical Cord arterial PHJust after the birth

Umbilical Cord arterial PH

© Copyright 2025. All Rights Reserved by MedPath